Skip to main content
Fig. 3 | Journal of Hematology & Oncology

Fig. 3

From: Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

Fig. 3

Overall survival for patients allotransplanted in front-line consolidation (CR1/PR1), second-line consolidation (CR2 or more /PR2 or more), and/or refractory/progressive disease. This curve represent the probability of overall survival from the time of alloSCT (stem cell transplantation) for patients allotransplanted in front-line consolidation (pointed line, CR1/PR1), second-line consolidation (continuous line, CR2 or more/PR2 or more), and/or refractory/progressive disease (dotted line). The gray zones represent the 95% CI for each subgroup. Time is represented in months on the horizontal axis. Below the x-axis, the number of patients at risk for each group is detailed. The p value (log rank test) is significant (p < 0.01) comparing OS among groups

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us